Vertex Pharmaceuticals (NASDAQ: VRTX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Vertex Pharmaceuticals (NASDAQ: VRTX) through any online brokerage.
The latest price target for Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Piper Sandler on Wednesday, August 17, 2022. The analyst firm set a price target for 288.00 expecting VRTX to fall to within 12 months (a possible -3.75% downside). 23 analyst firms have reported ratings in the last year.
The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $299.23 last updated August 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for Vertex Pharmaceuticals.
Vertex Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Vertex Pharmaceuticals.
Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.